Watchlist Price Alert

Xeris Biopharma Inc. (XERS)

NASDAQ: XERS · Real-Time Price · USD

5.02

-0.14 (-2.71%)

At close: May 09, 2025, 3:59 PM

5.04

0.40%

After-hours: May 09, 2025, 05:42 PM EDT

Xeris Biopharma Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Net Income	-54.84M	-62.26M	-94.66M	-94.66M	-122.72M	-91.14M	-60.08M	-26.55M	-13.21M
Depreciation & Amortization	12.63M	13.16M	12.67M	12.67M	1.88M	1.47M	320K	177K	116K
Stock-Based Compensation	18.36M	10.72M	12.16M	11.38M	8.27M	6.48M	1.73M	499K	540K
Other Working Capital	10.79M	9.92M	-9.99M	-9.99M	19.98M	7.01M	345K	-140K	-32K
Other Non-Cash Items	-2.04M	-1.1M	3.52M	3.52M	961K	3.1M	560K	94K	49K
Deferred Income Tax	-2.27M	-1.25M	-1.42M	-1.42M	1.11M	536K	-414K	n/a	n/a
Change in Working Capital	-8.82M	-6.29M	-35.15M	-35.15M	11.85M	-2.8M	1.61M	1.12M	-3.58M
Operating Cash Flow	-36.98M	-47.02M	-102.89M	-102.89M	-95.53M	-80.56M	-56.28M	-24.66M	-16.09M
Capital Expenditures	-868K	-2.26M	-524K	-524K	-1.08M	-377K	-1.51M	-700K	-35K
Cash Acquisitions	n/a	n/a	n/a	38.47M	38.47M	377K	n/a	n/a	n/a
Purchase of Investments	-34.48M	-43.74M	n/a	-43.02M	-43.02M	-101.77M	-68.85M	n/a	n/a
Sales Maturities Of Investments	40.24M	40M	34.98M	34.98M	103.6M	74.75M	2.1M	n/a	n/a
Other Investing Acitivies	n/a	n/a	34.98M	4.55M	-27.03M	-377K	-66.75M	n/a	n/a
Investing Cash Flow	4.88M	-6M	34.46M	34.46M	97.96M	-27.41M	-68.26M	-700K	-35K
Debt Repayment	38.17M	n/a	102.72M	n/a	69.75M	25M	35M	n/a	-32K
Common Stock Repurchased	-3.73M	-1.01M	-468K	-534K	-63K	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	1.73M	-604K	-4.78M	781K	-9.51M	55.53M	-333K	-336K	-64K
Financial Cash Flow	36.17M	-1.61M	127.47M	127.47M	27.25M	126.06M	128.21M	35.14M	3.9M
Net Cash Flow	4.07M	-54.64M	59.04M	59.04M	29.67M	18.08M	3.67M	9.78M	-12.22M
Free Cash Flow	-37.85M	-49.29M	-103.42M	-103.42M	-96.62M	-80.94M	-57.79M	-25.36M	-16.12M